WO2009093104A2 - Use of transesterified olive oil in the cosmetic field - Google Patents
Use of transesterified olive oil in the cosmetic field Download PDFInfo
- Publication number
- WO2009093104A2 WO2009093104A2 PCT/IB2008/054327 IB2008054327W WO2009093104A2 WO 2009093104 A2 WO2009093104 A2 WO 2009093104A2 IB 2008054327 W IB2008054327 W IB 2008054327W WO 2009093104 A2 WO2009093104 A2 WO 2009093104A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- olivate
- cetearyl
- olive oil
- sorbitan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Definitions
- This invention refers to the use of transesterified olive oil in the cosmetic field for the improvement of skin-penetration properties .
- the normal physiological barrier function of the epi- dermis is hence based on highly regular laminae, into which intercellular lipids penetrate.
- intercellular lipids are integrated in laminar gel phases and in laminar liquid crystals .
- Emollients provide partial occlusion of the pores and may soften, humidify and improve the appearance of the stratum corneum of the skin .
- humectants are generally hygroscopic molecules, such as for example urea or glycerol, capable of binding with atmospheric humidity, and they help keep skin water in balance.
- emollients nor humectants, however, affect the integrity of the barrier function of the skin.
- the skin lies on the surface of the body and serves as a sheath for the protection of inner organs, preventing them from coming into direct contact with the environment.
- the skin is extremely complex and has both intracrinous and paracrinous capabilities.
- the skin protects from UV radiation (melanogenesis) , provides immune protection and has a barrier function which prevents the penetration of foreign particles . It is also dynamically involved in the management of the inner levels of water. It is also the seat of vitamin D photoproduction and of the distribution of vitamin E, introduced nutritionally.
- the main skin layers are the dermis and the epidermis .
- the dermis is the site of the synthesis of the extracellular components, such as collagen, elastin and the glycosaminoglycans which are produced and secreted by the dispersed, resident fibroblastic cells.
- epidermal cell density is much higher and is represented predominantly by keratinocytes .
- the epidermis renews itself constantly through an outward flow and the differentiation of cells which origi- nate from the epidermal stratum basale up to the stratum corneum (SC) .
- SC stratum corneum
- the stratum corneum the outermost layer of the epidermis, supplies most of the permeability barrier, which is mainly supplied by the organised embedding of keratinocytes into an extra-cellular matrix rich in lipids .
- Chemical analyses have shown that the intercellular lipids of the stratum corneum consist mainly of ceramides, cholesterol, cholesterol esters and fatty acids, themselves being synthesised by keratinocytes. The three-dimensional organisation of those lipids has been the subject of various studies with the suggestion of various different mod- els (Madison, 2003) .
- the fats of the stratum corneum exist in the form of a crystalline gel, arranged as multi-laminar system which is found among keratinocytes (bricks) .
- a way to visualise the organisation of the lipids of the stratum corneum and the keratinocytes is to imagine a brick wall wherein the bricks representing keratinocytes are neatly juxtaposed and chelated in lipidic layers of mortar.
- the integrity of cell components is well-known and, in particular, the lipidic layers of the stratum corneum must necessarily maintain barrier function integrity. The destruction of the barrier function of the stratum corneum will lead to an increase of trans-epidermal water loss and to a consequent reduction in the level of skin hydration, with the negative consequences already illustrated above.
- lipidic laminae crystalline gel
- other classes of lipids originating from sebum also play an important role in the stratum corneum.
- the primary lipids found in sebum are: cholesterol, sterol and wax esters, triglycerides and squalene (Stewart, 1992) .
- Triglycerides can be produced inside the sebaceous gland and be released in the form of free fatty acids .
- the sebum fats (or the surface lipids of the skin) perform an anti-microbic action (Geor- gel, 2005; Willie, 2003) , as transient antioxidants (alfa-tocopherol) (Thiele, 1999), as well as supplying important molecules having targeted, biological purposes.
- glycerol more likely obtained by hydrolysis of triglycerides, acts as hygroscopic agent and participates in the capability of retaining the water of the stratum corneum (Fluhr, 2003) .
- fatty acids such as oleic acid and Ii- noleic acid
- PPARs peroxysome-proliferator-activated receptors
- Keratinocyte exfoliation is a process neces- sary for epidermal renewal and may be obtained through the proteolytic action of various enzymes (Houben, 2007) . It is suggested that the desquamation phenomenon may cause a certain degree of structural disorganisation in the intercellular, lipidic laminar matrix of the stratum corneum (Norlen, 2001, Sheu, 1999) .
- the exfoliation process could be represented as a destabilising operation which opens small gaps in the underlying lipidic matrix (in the same way as the removal of a brick from a wall should crush the surrounding mortar) .
- micropores may become paths for the sebaceous lipids to mix with the lipidic counterpart of the stratum corneum. Intermixing of sebaceous lipids with those features of inner layers of the stratum corneum might then occur. Together, these studies have established the physiological importance of sebum products in the skin surface as well as for the entire epidermis .
- the object of the present invention is that of designing high- penetration dermatological agents which, on the one hand, allow faster penetration of the active ingredients into the skin and, on the other hand, act as biomimetic restructuring agents .
- the present invention is mainly based on fatty acid compositions similar to those found in the skin for generating skin-compatible liquid crystals, so as to mimike the molecular organisation of the intercellular lipidic laminae of the stratum corneum.
- the liquid crystals thus formed must have the opportunity to cross skin layers at high speed as well as to integrate physiologically in the lipidic barrier of the skin and to strengthen the integrity thereof.
- fig. 1 shows the haematoxylin-eosin stain of a histological section of the RHE (epidermis - porous membrane) ;
- fig. 2 shows the accumulation of caffeine on the other side of the porous membrane;
- fig. 3 is a scanning electron microscope (SEM) picture showing the liquid crystal structure of cetearyl-olivate, sorbitan-olivate; fig.
- fig. 4 is a diagram showing the effect of the presence of cetearyl-olivate, sorbitan-olivate and of other lipidic compositions on skin barrier integrity;
- fig. 5 is a diagram showing a comparison between the hydration properties of glycerine and of cetearyl-olivate, sorbitan-olivate;
- fig. 6 is a diagram showing the functional effectiveness for skin hydration of cetearyl-olivate, sorbitan-olivate;
- fig. 7 is a picture of the mechanism of action of esters accord- ing to the present invention.
- olive oil is a mixture of fatty acid esters, varying according to its origin and to the type of olives employed for obtaining it, depending on years and on the processing method. However, since the percentages of the different esters vary within well-defined and widely-known ranges, although with a certain degree of variability, olive oil may be considered as a defined composition.
- Olive oil transesterification may be performed by any alcohol or alcohol mixture, according to the normal procedures of organic chemis- try. Particularly valid results have been obtained by performing the transesterification with cetearyl alcohol and/or sorbitol.
- olive oil firstly undergopes saponification, under usual conditions.
- the obtained fatty acids are then esterified, partly with cetearyl alcohol, partly with sorbitan, the obtained products being endly mixed to- gether.
- the Applicant has verified the effectiveness in transepidermal penetration of the skin-compatible liquid crystals generated by cetearyl-olivate, sorbitan-olivate, obtained by olive oil transesteri- fication. This involves, on the one hand, the ability to withhold per- spiration water, so as to obtain a strong hydrating effect and, on the other hand, that such crystals may be used to improve transepidermal penetration of biologically-active molecules.
- the ingredient (INCI: cetearyl-olivate, sorbitan-olivate) used in the following of the present exemplifying description is a complex combination of fatty acids, chemically related to the lipidic composition of the skin surface, which has the distinctive property of self-emulsifying in hydrophilic or lipophilic means.
- Cetearyl-olivate, sorbitan-olivate therefore represents a single biomimetic, restructuring agent which is entrusted with the double feature of 1) re-establishing and maintaining skin barrier integrity and 2) itself providing the emulsifying base. This leads to the creation of cosmetic formulations which are biologically functional with "physiologically" natural skin perception following application .
- the Applicant has succeeded in deriving the cosmetic ingredients, such as cetearyl-olivate, sorbitan-olivate, entrusted with a physiological action through the natural affinity thereof for the lipidic laminar system of the stratum corneum.
- the ingredient cetearyl-olivate, sorbitan-olivate adopts a liquid crystal configuration when it is emulsified, as highlighted in fig. 3.
- Those liquid crystals have a molecular structure similar to the one observed in the lipidic laminae of the stratum corneum.
- the walls of the liquid crystals consist of alternate layers of fatty acids and water, therefore reproducing the standard intercellular lipidic matrix structure of the stratum corneum (Norlen, 2001) .
- the biomimetism of cetearyl-olivate, sorbitan-olivate is therefore twofold 1) chemical mimetism with the lipidic composition of the skin surface and 2) structural mimetism with the intercellular, lipidic, laminar organisation of the stratum corneum.
- chemical mimetism with the lipidic composition of the skin surface
- structural mimetism with the intercellular, lipidic, laminar organisation of the stratum corneum.
- the skin-penetration properties of transesterified olive oil together with the characteristic structure thereof, allow to embed into said structure cosmetically-active and/or dermatologically-active molecules, in order to be able to bring them into the innermost layers of the skin, obtaining a more marked and/or more timely effect.
- transesterified olive oil as such once penetrated into the innermost layers of the skin, is able to embed itself and act as a barrier, so as to avoid excessive evaporation of water through the skin, which leads to an optimal hydrating effect, devoid of any negative consequence.
- EXAMPLE 1 An in-vitro Reconstructed Human Epidermis (RHE) system has been used. As biologically-active molecule, caffeine was chosen. When it is applied to the RHE surface, caffeine has the ability of penetrating into the epidermal layers . Transepidermal penetration of caffeine may be quantified by using a radioactive marker. Caffeine may also be in- tegrated in various formulations (emulsions) to verify the effect of said agent in improving the transepidermal penetration rate .
- RHE Human Epidermis
- RHE Human skin keratinocytes were dispersed on an artificial porous membrane and the differentiation of said keratinocytes was induced up to a phase reported as day 13.
- Reconstructed Human Epidermis (RHE) grows in a culture medium defined in a water-air interface environment. The histological organisation of the RHE is shown in fig. 1 and shows a typical configuration of epidermis with a layer of stratum corneum.
- RHE is arranged in plates having 12 wells each in the presence of 1 ml of maintenance medium at 37 0 C, 5% CO 2 .
- the RHE in each well represented an individual experimental condition. Any substance applied to the tip of the RHE having the ability of penetrating transepidermally may be gathered in the culture medium below the RHE and quantified using suitable detection methods .
- Radioactive caffeine C-caffeine, lmCi/m, 0.04 mM added to 0.339 mM of cold caffeine
- This mixture is representative of a water-soluble, biologically-active molecule.
- Caffeine was tested pure or integrated in the various formulae . Caffeine was integrated in the formula with weak shaking and kept at room temperature overnight before the test.
- a kinetic sample was arranged on the culture medium below RHE with 7 kinetic times of 1, 2, 3, 4, 5, 6 and 24 hours. The radioactivity contained in the collected samples was measured using liquid scintillation. The results are expressed as cpm (counts per minute) of released caffeine and represent the relative concentration of caffeine in the epidermis .
- MTT salt (4, 5-dimetil-tiaol-2-il) -2, 5 diphenyltetrazolium bromide
- MTT salt may be reduced through the mitochondrial enzyme succinate-dehydrogenase found in living cells.
- the reduction product, formazan crystals may be quantified by optic density at 540 mm and is proportional to the number of living cells .
- the MTT assay was performed on the RHE at the 24 hour instant.
- TEWL transepidermal water loss
- Ten volunteers have ap- plied topically identical concentrations (5%) of the following ingredients: cetearyl-olivate, sorbitan-olivate; cetearyl alcohol, cetearyl-glucoside and poliglyceril-3 methylglucose distearate.
- the results - see fig. 4 - have shown that the application of cetearyl- olivate, sorbitan-olivate reduced the increase of TEWL by 29% over control formulae (fig. 2) .
- Cetearyl alcohol, cetearyl-glucoside and poliglyceril-3 methylglucose distearate may be identified in categories as non-compatible lipidic compositions, due to the fact that they activate excessive water loss following application. This might be interpreted as a transient desta- bilisation of barrier integrity which leads to the forming of micropores through which water may come out. TEWL progressively regains base line values when barrier integrity is restored.
- the importance of the lipidic composition has been proven consisting of the appropriate, skin-compatible lipidic composition and ratio (Mao Qiang, 1995, De Pa- epe, 2002) .
- the skin hydrating effect of cetearyl-olivate, sorbitan-olivate was compared to that of glycerine- employing corneometry.
- Glycerine is produced and secreted by sebaceous glands and acts as a natural skin humectant (Fluhr, 2003) .
- Ten volunteers have applied a solution consisting of 2% glycerine and 0.4% xan- than gum and an emulsion of 4% cetearyl-olivate, sorbitan-olivate on different sites of the palm side of the forearm.
- the glycerine solution has produced a rapid increase of skin surface hy- dration, as can be seen in fig. 5.
- the skin hydration peak shown in fig. 5 progressively disappeared reaching significantly lower values than cetearyl-olivate, sorbitan- olivate from 45 minutes up to 7 hours after application.
- the cetearyl- olivate, sorbitan-olivate emulsion did not cause a transient peak in hydration, but resulted in a more stable long-term effect.
- This effect may be interpreted as a physiological penetration and as an integration of skin-compatible liquid crystals formed by cetearyl-olivate, sorbitan-olivate, thereby increasing the integrity of the stratum corneum.
- cetearyl-olivate was further clinically analysed for its functional hydration effect.
- Ten volunteers applied an emulsion consisting of cetearyl-olivate, sorbitan- olivate to one half of their face and Ceteareth-20, cetearyl alcohol to the other half, twice daily, for a period up to 45 days.
- Skin homeostasis is based to a high degree on the integrity of the stratum corneum barrier, which consists of keratinocytes embedded in a matrix rich in lipids .
- the integrity thereof guarantees protec- tion from environmental attacks and avoids excessive transepidermal water loss .
- the barrier function may be disrupted by noxious external agents, such as pollutants, strong detergents and aging factors which therefore affect the water evaporation rate, the level of skin sensitivity, and cellular functions . Finally, this may result in skin dry- ness, skin irritation and a weaker physiological response.
- liquid crystals have been generated which mimic both the lipidic composition of the skin surface and the molecular organisation of the intercellular lipidic laminae of the stratum corneum.
- the liquid crystals of cetearyl- olivate, sorbitan-olivate have the property of integrating physiologi- cally in the lipidic skin barrier. They act as biomimetic restructuring agents and restore the optimal integrity of the barrier function of the skin. Moreover, their similarity with the lipidic composition of the skin surface allows those liquid crystals to improve the sensory perception with part of the formulation.
- the suggested skin action of liquid crystals of cetearyl-olivate, sorbitan-olivate may be summed up in fig. 7.
- the dermatological compatibility of cetearyl-olivate, sorbitan- olivate makes it a key ingredient in the formulation of products which respect the chemical and structural homeostasis of the lipidic skin barrier and it is hence physiologically highly suitable. This dermatological compatibility also supports the physiological enhancement of delivery of actives through the epidermis .
- caffeine The ability to cause active ingredients to penetrate in the skin has been verified with caffeine, but such property is displayed with any active ingredient, such as antioxidants, free-radical scavengers, hyaluronic acid, collagen, botulinum toxin, cortison-like drugs, antibiotics, chemotherapeutic agents, wound-healing drugs, peptides.
- active ingredient such as antioxidants, free-radical scavengers, hyaluronic acid, collagen, botulinum toxin, cortison-like drugs, antibiotics, chemotherapeutic agents, wound-healing drugs, peptides.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/864,076 US8796217B2 (en) | 2008-01-25 | 2008-10-21 | Use of transesterified olive oil in the cosmetic field |
EP08871548A EP2247277A2 (en) | 2008-01-25 | 2008-10-21 | Use of transesterified olive oil in the cosmetic field |
JP2010543583A JP2011510059A (en) | 2008-01-25 | 2008-10-21 | Use of transesterified olive oil in the cosmetics field |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20080118 ITMI20080118A1 (en) | 2008-01-25 | 2008-01-25 | USE OF TRANSESTETERIFIED OLIVE OIL AS A MOISTURIZING SKIN. |
ITMI2008A000118 | 2008-01-25 | ||
ITAN2008A000020 | 2008-04-16 | ||
ITAN20080020 ITAN20080020A1 (en) | 2008-04-16 | 2008-04-16 | IMPROVEMENT OF COSMETIC PENETRATION PROPERTIES IN THE SKIN |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009093104A2 true WO2009093104A2 (en) | 2009-07-30 |
WO2009093104A3 WO2009093104A3 (en) | 2010-08-26 |
Family
ID=40901489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/054327 WO2009093104A2 (en) | 2008-01-25 | 2008-10-21 | Use of transesterified olive oil in the cosmetic field |
Country Status (5)
Country | Link |
---|---|
US (1) | US8796217B2 (en) |
EP (1) | EP2247277A2 (en) |
JP (1) | JP2011510059A (en) |
KR (1) | KR20110007088A (en) |
WO (1) | WO2009093104A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010073278A1 (en) * | 2008-12-24 | 2010-07-01 | B & T S.R.L. | Use of olive-oil-derived compounds as surfactants |
WO2011085053A2 (en) | 2010-01-07 | 2011-07-14 | The Gillette Company | Personal care compositions comprising a multi-active system for down regulating cytokines irritation |
WO2011088073A2 (en) | 2010-01-15 | 2011-07-21 | The Gillette Company | Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof |
US20130123220A1 (en) * | 2010-07-22 | 2013-05-16 | Evidence Soluções Farmacêuticas Ltda Epp | Stable Topical Composition and a Process for Producing a Stable Topical Composition |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2504658A (en) * | 2012-06-15 | 2014-02-12 | Corvin Medcat | Modular footwear construction |
US11013681B2 (en) * | 2015-07-15 | 2021-05-25 | Bakel Srl | Cosmetic composition |
US10898537B2 (en) | 2015-07-31 | 2021-01-26 | Delivra Inc. | Transdermal formulations for delivery of capsaicinoids |
IL308091A (en) | 2016-09-13 | 2023-12-01 | Allergan Inc | Stabilized non-protein clostridial toxin compositions |
US10206870B2 (en) * | 2016-12-12 | 2019-02-19 | Johnson & Johnson Consumer Inc. | Topical composition containing glycerin and yeast extract |
EP3697445A4 (en) | 2017-10-16 | 2021-07-14 | Delivra Inc. | Transdermal formulation for delivery of hydrophobic compounds and process for the preparation thereof |
KR102312069B1 (en) * | 2019-12-31 | 2021-10-13 | 주식회사 제이엘비 | Natural cosmetic containing esters oil |
WO2022265603A1 (en) | 2021-06-15 | 2022-12-22 | Oezkan Oemer | Mesoporous dermal formulation with olive oil |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB450368A (en) | 1934-06-05 | 1936-07-16 | Chem Fab Vormals Sandoz | Process for the manufacture of detergent, cleansing, emulsifying, softening and dispersing agents |
US2333093A (en) * | 1939-03-03 | 1943-11-02 | Frederick E Dearborn | Cosmetic preparation |
FR1274354A (en) * | 1956-03-10 | 1961-10-27 | Surfactants obtained from triglycerides and polyethylene glycol | |
FR2377193A1 (en) | 1977-01-17 | 1978-08-11 | Foucard Marcelle | Non-irritant depilatory product - consisting of a lotion and a cream contg. linoleic acid and lipoxydase |
GB8712752D0 (en) | 1987-05-30 | 1987-07-01 | Tioxide Group Plc | Particulate material |
FR2634120B1 (en) | 1988-07-13 | 1990-09-14 | Transphyto Sa | NEW COSMETIC COMPOSITIONS BASED ON CHROMONE-CARBOXYLATES |
FR2636630B1 (en) | 1988-09-19 | 1993-03-19 | Oreal | NOVEL BENZOFURANNIC COMPOUNDS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USE OF SUCH COMPOSITIONS |
FR2658190B1 (en) * | 1990-02-15 | 1992-06-05 | Panmedica Sa | HYDROQUINONE AMINO ACID ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM. |
US5202125A (en) * | 1990-12-10 | 1993-04-13 | Theratech, Inc. | Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes |
US5227169A (en) * | 1991-05-17 | 1993-07-13 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
US5260336A (en) | 1992-04-30 | 1993-11-09 | New England Deaconess Hospital Corporation | Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness |
US5314685A (en) | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
PT589843E (en) | 1992-09-25 | 2002-04-29 | Novartis Ag | PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS |
GB9302710D0 (en) | 1993-02-11 | 1993-03-24 | Procter & Gamble | Cleansing compositions |
JPH06345617A (en) * | 1993-06-07 | 1994-12-20 | Nippon Saafuakutanto Kogyo Kk | Cosmetic and external preparation |
DE4338591A1 (en) | 1993-11-11 | 1995-05-18 | Siemens & Co Quellenprodukte | Process for the neutralization of acidic substances and for the saponification of oils, fats, waxes or the like |
DE4343264A1 (en) * | 1993-12-17 | 1995-06-22 | Henkel Kgaa | Deodorising preparations |
US5502076A (en) | 1994-03-08 | 1996-03-26 | Hoffmann-La Roche Inc. | Dispersing agents for use with hydrofluoroalkane propellants |
US5653970A (en) | 1994-12-08 | 1997-08-05 | Lever Brothers Company, Division Of Conopco, Inc. | Personal product compositions comprising heteroatom containing alkyl aldonamide compounds |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
FR2755371B1 (en) | 1996-11-07 | 1998-12-18 | Oreal | COSMETIC COMPOSITION IN THE FORM OF A TRANSPARENT FOAMING GEL |
IT1291520B1 (en) * | 1997-04-09 | 1999-01-11 | 3V Sigma Spa | ACRYLIC COPOLYMERS IN WATER EMULSION WITH BETTER ADHESIVE AND SUSPENDING POWER; NEW MONOMERS AND THEIR PREPARATION |
US5968528A (en) | 1997-05-23 | 1999-10-19 | The Procter & Gamble Company | Skin care compositions |
US6017549A (en) * | 1997-09-30 | 2000-01-25 | E-L Management Corp. | Non-irritating cosmetic and pharmaceutical compositions |
IT1297111B1 (en) | 1997-12-10 | 1999-08-03 | Keminova Italiana S R L | PROCEDURE TO OBTAIN LIPOPROTEINS, LIPOAMINO ACIDS, LIPID ESTERS AND GLUCOLIPIDS, STARTING FROM OLIVE OIL AND / OR ITS |
GB9814069D0 (en) | 1998-06-29 | 1998-08-26 | Procter & Gamble | Hair conditioning composition |
FR2790977B1 (en) * | 1999-03-19 | 2003-09-12 | Seppic Sa | NEW STABLE WATER-IN-OIL EMULSIONS CONTAINING OLEYL- AND / OR ISOSTEARYL-GLYCOSIDE EMULSIFIER |
FR2801501B1 (en) * | 1999-11-30 | 2003-02-28 | Oreal | COSMETIC COMPOSITION COMPRISING A WAX |
KR100402334B1 (en) * | 2000-06-23 | 2003-10-22 | 환인제약 주식회사 | Alprostadil-containing composition for external application |
AU2001278885A1 (en) | 2000-07-07 | 2002-01-21 | Collaborative Technologies, Inc. | Sunscreen composition with enhanced spf and water resistant properties |
FR2815254B1 (en) * | 2000-10-13 | 2003-02-07 | Sophim | FORMULATION CONTAINING A NON-FAT EMOLLIENT BASED ON WAX-ESTERS |
ITMI20012139A1 (en) | 2001-10-16 | 2003-04-16 | B & T S R L | NATURAL EMULSIFIER FOR COSMETICS |
FR2832057B1 (en) | 2002-02-22 | 2004-10-08 | Oreal | MAKE-UP REMOVER COMPOSITION |
US7612111B2 (en) * | 2003-03-20 | 2009-11-03 | Imagenetix, Inc. | Esterified fatty acid composition |
JP4515109B2 (en) * | 2004-02-18 | 2010-07-28 | 株式会社資生堂 | Skin external preparation and fiber having a lipolysis promoting effect |
CA2571621A1 (en) * | 2004-07-07 | 2006-02-09 | Dpc Products, Inc. | Gilsonite derived pharmaceutical delivery compositions and methods : cosmetic and nail applications |
WO2007133768A2 (en) * | 2006-05-15 | 2007-11-22 | The Procter & Gamble Company | Method of enhancing penetration of water-soluble actives |
FI121468B (en) * | 2006-06-07 | 2010-11-30 | Valtion Teknillinen | Compounds derived from betulin as antimicrobial agents |
RU2010108927A (en) * | 2007-09-03 | 2011-11-27 | Лар Процесс Анализерс Аг (De) | METHOD FOR DETERMINING CHEMICAL NEEDS IN OXYGEN OR WASTE WATER |
-
2008
- 2008-10-21 WO PCT/IB2008/054327 patent/WO2009093104A2/en active Application Filing
- 2008-10-21 EP EP08871548A patent/EP2247277A2/en not_active Withdrawn
- 2008-10-21 JP JP2010543583A patent/JP2011510059A/en active Pending
- 2008-10-21 KR KR1020107018018A patent/KR20110007088A/en not_active Application Discontinuation
- 2008-10-21 US US12/864,076 patent/US8796217B2/en active Active
Non-Patent Citations (1)
Title |
---|
None |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010073278A1 (en) * | 2008-12-24 | 2010-07-01 | B & T S.R.L. | Use of olive-oil-derived compounds as surfactants |
WO2011085053A2 (en) | 2010-01-07 | 2011-07-14 | The Gillette Company | Personal care compositions comprising a multi-active system for down regulating cytokines irritation |
WO2011088073A2 (en) | 2010-01-15 | 2011-07-21 | The Gillette Company | Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof |
US20130123220A1 (en) * | 2010-07-22 | 2013-05-16 | Evidence Soluções Farmacêuticas Ltda Epp | Stable Topical Composition and a Process for Producing a Stable Topical Composition |
US9572770B2 (en) * | 2010-07-22 | 2017-02-21 | Evidence Solucões Farmacêuticas Ltda Epp | Stable topical composition and a process for producing a stable topical composition |
Also Published As
Publication number | Publication date |
---|---|
US8796217B2 (en) | 2014-08-05 |
WO2009093104A3 (en) | 2010-08-26 |
US20110021439A1 (en) | 2011-01-27 |
JP2011510059A (en) | 2011-03-31 |
EP2247277A2 (en) | 2010-11-10 |
KR20110007088A (en) | 2011-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8796217B2 (en) | Use of transesterified olive oil in the cosmetic field | |
Betz et al. | In vivo comparison of various liposome formulations for cosmetic application | |
JP3652270B2 (en) | Compositions containing ascorbic acid in combination with ascorbic acid derivatives | |
CN109846757B (en) | Sebum biomimetic composition and cosmetic containing same | |
US20010006680A1 (en) | Skin care moisturizers and cleansers | |
KR101682452B1 (en) | Liquid crystal base for recovering disrupted skin barrier and cosmetic composition comprising the same | |
CN105943491A (en) | Moistening and moisturizing essence and preparation method thereof | |
KR101640857B1 (en) | Water in Oil type make-up cosmetic composition for improving skin | |
WO2008133482A1 (en) | Emulsion composition containing double-stabilized ceramide nano capsule, method for manufacturing the same, and cosmetic composition containing the same | |
EP1633441B1 (en) | Cosmetic product containing mineral water for remineralising and rejuvenating the skin | |
KR20090017336A (en) | Cosmetic composition containing liquid crystal complex for enhancing moisturizing effect on the skin and for reducing skin roughness | |
KR100912242B1 (en) | Nanoemusion containing lecithin and polyglycerin fatty acid ester and moisturizer composition comprising thereof | |
JP2011079820A (en) | Liposome which encapsulates oxazolidin-2-one compound | |
KR20070103899A (en) | A carrier carrying ingredients for improvement of water content in skin and manufacturing method thereof, a cosmetic composition and a mask containing the same | |
JP2005330285A (en) | Skin moisturizing cosmetic composition | |
CN106389168A (en) | Positively-charged oil-in-water nano cream with spot whitening effect and preparation method of positively-charged oil-in-water nano cream | |
KR100748035B1 (en) | Cosmetic composition containing useful ingredients capsulated with non-phospholipid vesicle | |
KR20090056300A (en) | Cosmetic composition for improving the skin elasticity | |
KR20090020407A (en) | Nano liposome composition and cosmetic comprising nano liposome produced therefrom | |
Kligman | A brief history of how the dead stratum corneum became alive | |
EP2381917A1 (en) | Moisturizing mixture, cosmetic and/or pharmaceutical compositions containing the moisturizing mixture, use of the moisturizing mixture, and cosmetic method | |
Elsner | What textile engineers should know about the human skin | |
KR101598210B1 (en) | transparent gel solubilization composition containing ceramide, peptide, and hyaluronic acid | |
CN113730289A (en) | Eye and lip care composition with multiple repairing effects and application thereof | |
KR100858626B1 (en) | Cosmetic Composition for Protecting lip Comprising Ceramide and Synthetic Palmitoylpentapeptide as an Active Ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2010543583 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008871548 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20107018018 Country of ref document: KR Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08871548 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12864076 Country of ref document: US |